ADMA Biologics, Inc.ADMANASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+10.7%
5Y CAGR+17.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+10.7%/yr
vs +20.8%/yr prior
5Y CAGR
+17.2%/yr
Recent deceleration
Acceleration
-10.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $101.32M | +25.8% |
| 2024 | $80.57M | +19.7% |
| 2023 | $67.31M | -9.8% |
| 2022 | $74.63M | +25.3% |
| 2021 | $59.55M | +29.9% |
| 2020 | $45.84M | +46.6% |
| 2019 | $31.27M | -10.9% |
| 2018 | $35.08M | +9.4% |
| 2017 | $32.06M | +48.2% |
| 2016 | $21.63M | - |